Treatment effectiveness and preference in patients with schizophrenia switched from oral standard of care atypical antipsychotics to aripiprazole once-monthly: a brief report over a six-month period
BackgroundSchizophrenia is a chronic and disabling psychiatric disorder characterized by poor treatment adherence, often leading to relapse and functional decline. Long-acting injectable antipsychotics (LAIs), such as aripiprazole once-monthly (AOM), offer a potential solution by improving adherence...
Gardado en:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2025-12-01
|
| Series: | Frontiers in Psychiatry |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1680394/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|